Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohammadali Sahraian"'
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 32, Iss 207, Pp 95-101 (2022)
Background and purpose: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. The purpose of this study was to report the information of MS patients registered in Mazandaran MS Registry System
Externí odkaz:
https://doaj.org/article/1b87ea391cc7478e9ad0e91e6f0ae4ab
Autor:
Rouhullah DEHGHANI, Masoud YUNESIAN, MohammadAli SAHRAIAN, HamidReza GILASI, Vahid KAZEMI-MOGHADDAM
Publikováno v:
Iranian Journal of Public Health, Vol 44, Iss 6 (2015)
Background: Multiple Sclerosis (MS) is an autoimmune disease with unknown factor. The prevalence and incidence rate of this disease had an upward trend in many regions in the world such as Middle east and consequently in Iran over the recent years. A
Externí odkaz:
https://doaj.org/article/6cbcd3fe2ed845a7a9fd5fb6a6eaa14b
Autor:
Ali Amini Harandi, Hossein Pakdaman, Faezeh Karamiani, Faezeh Mohammadi, Siavash Shirzadeh Barough, Fatemeh Siavoshi, Saba Ilkhani, Mohammadali Sahraian
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 44(1)
Fampridine is a potassium channel blocker drug used to improve walking ability in patients with multiple sclerosis (MS). We evaluated the effect of fampridine in patients with MS in the acute phase of transverse myelitis.In a randomized, placebo-cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6585ffc6ec57bf94c2e2fafdd8576d
https://pubmed.ncbi.nlm.nih.gov/36094772
https://pubmed.ncbi.nlm.nih.gov/36094772
Publikováno v:
Multiple Sclerosis and Related Disorders. 59:103577
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bf39b34dec4f7425a82e92700edb3ee
https://doi.org/10.1016/j.msard.2022.103577
https://doi.org/10.1016/j.msard.2022.103577